Stoke Therapeutics, Inc. company logo
Stoke Therapeutics, Inc. logo

Stoke Therapeutics, Inc. (STOK) EBITDA

Annual EBITDA

-$99.20M$13.11M+11.67%

Summary

Current Value
As of today, STOK annual EBITDA is -$99.20M, up +11.67% on
Historical Performance
STOK annual EBITDA is down -16.58% over the past 3 years, and down -181.58% over the past 5 years
All-Time High Comparison
STOK annual EBITDA is currently -1723.10% below its historical high of -$5.44M set on
3-Year Low Comparison
STOK annual EBITDA is +11.67% above its 3-year low of -$112.30M reached on
Sector Comparison
STOK annual EBITDA is higher than 17.15% of companies in Healthcare sector

EBITDA Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

STOK Performance
MetricDateValue1Y3Y5Y15Y
Annual EBITDA-$99.20M+11.7%-16.6%-181.6%-1723.1%
Quarterly EBITDA-$42.10M-45.7%-60.5%-218.6%-2139.5%
TTM EBITDA$31.43M+127.9%+131.8%+165.2%+1771.6%
Price$29.42+229.8%+201.7%-49.5%
PE Ratio44.58
Annual Revenue$36.56M+316.3%+100.0%+100.0%+100.0%
Annual EPS-$1.65+30.8%+29.5%+8.4%-867.4%
Annual EBIT-$101.37M+11.7%-17.8%-184.1%-1725.2%
Annual Net Income-$88.98M+15.0%-3.7%-175.3%-1501.0%

EBITDA Highs

STOK Annual EBITDA Highs Comparison
PeriodHighDateCurrent
3Y-$99.20Mat high
5Y-$52.16MN/A-90.2%
All-$5.44M-1723.1%

EBITDA Lows

STOK Annual EBITDA Lows Comparison
PeriodLowDateCurrent
3Y-$112.30M+11.7%
5Y-$112.30M+11.7%
All-$112.30M+11.7%

EBITDA History

YearValueChange
-$99.20M+11.7%
-$112.30M-9.2%
-$102.81M-20.8%
-$85.09M-63.1%
YearValueChange
-$52.16M-48.1%
-$35.23M-180.3%
-$12.57M-131.0%
-$5.44M-

FAQ

  • What is the current annual EBITDA of STOK?

    As of today, STOK annual EBITDA is -$99.20M

  • What is 1-year change in STOK annual EBITDA?

    STOK annual EBITDA is up +11.67% year-over-year

  • What is 3-year change in STOK annual EBITDA?

    STOK annual EBITDA is down -16.58% over the past 3 years

  • How far is STOK annual EBITDA from its all-time high?

    STOK annual EBITDA is currently -1723.10% below its historical high of -$5.44M set on December 31, 2017

  • How does STOK annual EBITDA rank versus sector peers?

    STOK annual EBITDA is higher than 17.15% of companies in Healthcare sector

  • When is STOK next annual earnings release?

    The next annual earnings release for STOK is on

EBITDA Formula

EBITDA = + + +

Data Sources & References

  1. STOK Official Website www.stoketherapeutics.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1623526/000119312525264720/0001193125-25-264720-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1623526/000095017025041170/0000950170-25-041170-index.htm
  4. STOK Profile on Yahoo Finance finance.yahoo.com/quote/STOK
  5. STOK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/stok